Differentiate drug product candidates in early development or promote high potential formulations from preclinically developed candidates, in advance of performing clinical trials.
The data resulting from our TIM studies helps differentiate drug product candidates in early development or promote high potential formulations from preclinically developed candidates, in advance of performing clinical trials.
By simulating the physiological reality of the human gastrointestinal tract, we measure the availability for absorption of your oral formulation through the gut wall (i.e., bioaccessibility) during digestion by the use of dialysis membrane.
Applications include:
- Release, dissolution and bioaccessibility testing of APIs under simulated fasted and fed-state conditions
- Comparison of different types of formulations
- Dose escalation comparison studies
- Bio-equivalence studies
- Proof of concept studies
Want to know more?
Contact us
